Back
Novo Nordisk AS Vs. Fabrinet Industry Stock Comparison
Sell
37
NONOF
Novo Nordisk AS
Last Price:
$76.68
Seasonality Move:
7.34%
Buy
56
FN
Fabrinet
Last Price:
$220.16
Seasonality Move:
2.27%
Sell
37
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $76.68. The Score for NONOF is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $76.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
FN Stock Price Chart
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.95 | Sell |
Relative Strength Index (14 RSI): | 38.04 | Sell |
Chaikin Money Flow: | 188367 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (79.57 - 89.83) | Sell |
Bollinger Bands (100): | (82.76 - 108.34) | Sell |
FN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.77 | Sell |
Relative Strength Index (14 RSI): | 54.68 | Buy |
Chaikin Money Flow: | 117700 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (195.63 - 225.15) | Buy |
Bollinger Bands (100): | (211.17 - 249.15) | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.59 | Sell |
20-day SMA: | 84.69 | Sell |
50-day SMA: | 84.37 | Sell |
200-day SMA: | 114.37 | Sell |
8-day EMA: | 80.78 | Sell |
20-day EMA: | 83.7 | Sell |
50-day EMA: | 87.31 | Sell |
200-day EMA: | 104.05 | Sell |
FN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 201.13 | Buy |
20-day SMA: | 209.75 | Buy |
50-day SMA: | 219.4 | Buy |
200-day SMA: | 232.87 | Sell |
8-day EMA: | 207.4 | Buy |
20-day EMA: | 208.55 | Buy |
50-day EMA: | 216.92 | Buy |
200-day EMA: | 221.86 | Sell |
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Fabrinet Earnings Growth & FN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.02 per share, an increase this year of $1.55 per share, and an increase next year of $1.33 per share.
Novo Nordisk AS Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fabrinet Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |